BioNTech

Page 2 of 6

Structural images of the main COVID-19 virus variants from Alpha to Omicron.
Health

BioNTech and London A.I. firm create ‘early warning system’ to spot dangerous new COVID-19 variants before they spread

By
January 12, 2022
Photo illustration of a syringe jabbing a stock chart that shows shares rising and then falling
Finance

Omicron is upping booster jab demand. So why are COVID vaccine makers’ shares tanking?

By
December 29, 2021
A health care worker prepares a Moderna booster vaccine dose.
Health

Moderna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries

By
December 27, 2021
COVID-19 vaccine in front of Israeli flag
Health

Israel to give fourth COVID vaccine doses to combat Omicron, despite lack of data on second boosters

By
December 22, 2021
Europe taps Pfizer and BioNTech to provide 180 million more vaccines to face ‘ferocious’ Omicron threat
Health

Europe taps Pfizer and BioNTech to provide 180 million more vaccines to face ‘ferocious’ Omicron threat

By
December 17, 2021
J&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
Health

J&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study

By
December 17, 2021
A desperate Germany turns to vaccine-hesitant Eastern Europe for COVID jabs
International

A desperate Germany turns to vaccine-hesitant Eastern Europe for COVID jabs

By
December 16, 2021
A soldier in Switzerland prepares vaccine doses.
Health

Germany’s new health minister delivers a bombshell: The country doesn’t have enough COVID-19 vaccines

By
December 15, 2021
The world’s most sought after vaccine is still blocked in China
Newsletters

The world’s most sought after vaccine is still blocked in China

By Grady McGregor and Eamon Barrett
December 14, 2021
Pfizer and BioNTech say booster dose is necessary to fight Omicron variant
Health

Pfizer and BioNTech say booster dose is necessary to fight Omicron variant

By Naomi Kresge and Bloomberg
December 8, 2021
Pfizer’s vaccine has a ‘robust, but not complete’ loss of immune protection against Omicron, tests show
Health

Pfizer’s vaccine has a ‘robust, but not complete’ loss of immune protection against Omicron, tests show

By Antony Sguazzin, Jason Gale and Bloomberg
December 8, 2021
A health worker speaks with a patient in the reception area of a Testaro Covid-19 testing site in the Goodwood district of Cape Town, South Africa,
Health

Omicron vaccine to begin clinical trial in South Africa

By
December 6, 2021
Pfizer-BioNTech and Moderna jabs perform best in study of COVID booster vaccines
Health

Pfizer-BioNTech and Moderna jabs perform best in study of COVID booster vaccines

By Suzi Ring, Irina Anghel and Bloomberg
December 3, 2021
Global drugmakers could roll out Omicron-adapted COVID vaccines in 100 days
Health

Global drugmakers could roll out Omicron-adapted COVID vaccines in 100 days

By
November 29, 2021
Pfizer’s COVID-19 vaccine generated the strongest immune response in study of 4 jabs
Health

Pfizer’s COVID-19 vaccine generated the strongest immune response in study of 4 jabs

By Jason Gale and Bloomberg
November 15, 2021

Most Popular